Celcuity Inc.
NASDAQ:CELCBiotechnology
-$4.04 today
- Market cap
- $2.72B
- Beta
- 0.12
- P/E (TTM)
- -23.7
- EPS (TTM)
- -$3.54
Volume 0.98M
Average 1.24M
CELC Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Celcuity Inc.NASDAQ: CELC
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development dips below year-ago levels
Q2 FY2026 research & development of $31.08M fell 22.7% year over year, behind the +2.4% change in trailing-twelve-month research & development. Sequentially, it fell 6.0% from the prior quarter. Over 3 fiscal years it compounded at +60.2% a year.
Context
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -22.7% toward the trailing-twelve-month pace of +2.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 145M USD
- Year-over-year change
- +39.1%
- 4-year CAGR
- +54.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 145M | +39.1% |
| FY2024 | 2024-12-31 | 104.2M | +72.0% |
| FY2023 | 2023-12-31 | 60.59M | +71.7% |
| FY2022 | 2022-12-31 | 35.29M | +37.0% |
| FY2021 | 2021-12-31 | 25.76M | — |
Research & Development vs competitors
How CELC compares with its peers on the latest reported figures
- CELC's LTM Jun 2026 research & development of $136.69M is the highest of the 6 companies compared; the peer median is $53.69M.
- Its year-over-year change of +2.4% is the 5th highest of 6, against a peer median of +6.9%.
- Over three fiscal years its annual growth of +60.2% compares with a peer median of -1.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $136.69M | +2.4% | +60.2% | — | |
| LTM Jun 2026 | $88.21M | -7.8% | -12.9% | 28.6% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $59.21M | +38.6% | — | 14.9% |
| LTM Mar 2026 | $53.69M | +5.8% | +4.9% | 15.8% | |
| LTM Mar 2026 | $52.16M | +6.9% | -8.2% | 80.9% | |
| LTM Jun 2026 | $38.17M | +9.5% | +6.9% | 5.0% | |
| Peer median (excluding CELC) | $53.69M | +6.9% | -1.6% | 15.8% | |
Competitors are the stored peer set for CELC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 167K |
| Gross Profit | 0 | 0 | 0 | 0 | (167K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 25.76M | 35.29M | 60.59M | 104.2M | 145M |
| Selling, General & Admin | 2.6M | 4.38M | 5.64M | 9.06M | 27.2M |
| Operating Expenses | 28.36M | 39.39M | 66.23M | 113.27M | 172.19M |
| Depreciation & Amortization | 303.24K | 210.92K | 142.77K | 129.95K | 167K |
| EBITDA | (28.04M) | (38.05M) | (58.31M) | (101.37M) | (159.73M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (28.36M) | (39.39M) | (66.23M) | (113.27M) | (172.19M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 13.26K | 1.13M | 7.78M | 11.77M | 12.3M |
| Interest Expense | 1.26M | 2.11M | 5.33M | 10.28M | 17.15M |
| Other Income / Expenses | (1.25M) | (978.95K) | 2.45M | 1.49M | (4.85M) |
| Income Before Tax | (29.61M) | (40.37M) | (63.78M) | (111.78M) | (177.04M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (29.61M) | (40.37M) | (63.78M) | (111.78M) | (177.04M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (2.28) | (2.68) | (2.69) | (2.83) | (3.78) |
| EPS (Diluted) | (2.28) | (2.68) | (2.69) | (2.83) | (3.78) |
| Weighted Avg Shares | 13.38M | 15.42M | 23.68M | 39.45M | 52.54M |
| Weighted Avg Shares (Diluted) | 13.38M | 15.42M | 23.68M | 39.45M | 52.54M |
Celcuity Inc.
NASDAQ:CELC
Intrinsic Alpha fair value
Locked
Current Price
$55.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.